JPRN-UMIN000019670已完成未知
Dose-Finding Study and Assessment of Safety of a Supplement Containing Mushroom Extract for Reducing LDL-C, T-Chom, and Body Fat - Dose-Finding Study and Assessment of Safety of a Supplement Containing Mushroom Extract for Reducing LDL-C, T-Chom, and Body Fat
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[1]Individuals using medical products [2]Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease [3]Individuals who are sensitive to test product or other foods, and medical products [4]Individuals who have a history of hepatitis [5]Individuals with serious anemia [6]Individuals whose amount of dietary intake or exercise has changed significantly in the past one year [7]Individuals whose weight has changed significantly in the past one year [8]Individuals whose average number of cigarettes for smoking is over 21/day [9]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [10]Individuals whose life style will change during the test period (ex. a night shift, travel for a long time, job transfer) [11]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments in the past 3 month or will ingest those foods during the test period [12]Individuals who participated in other clinical studies in the past three months [13]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [14]Individuals who are or are posslibly, or are lactating [15]Individuals judged inappropriate for the study by the principal
研究者
相似试验
已完成
不适用
ReoGlio: REOLYSIN® plus GM-CSF in combination with standard of care chemotherapy and radiotherapy for patients with glioblastoma multiforme (GBM)Specialty: Cancer, Primary sub-specialty: Brain CancerUKCRC code/ Disease: Cancer/ Malignant neoplasms of eye, brain and other parts of central nervous systemCancerGlioblastoma multiformeISRCTN70044565niversity of Leeds24
进行中（未招募）
不适用
Safety and dose finding study of BM32 in subjects suffering from grass pollen allergyEUCTR2011-003368-64-ATBiomay AG
进行中（未招募）
不适用
To find a safe and effective dose of K-877 for targeted patientsdyslipidemia (eg hyperlipidemia, hypertriglyceridaemia)MedDRA version: 18.0Level: LLTClassification code 10020667Term: HyperlipidemiaSystem Organ Class: 100000004861EUCTR2013-001517-32-NLKowa Research Europe350
进行中（未招募）
不适用
To find a safe and effective dose of K-877 for targeted patientsdyslipidemia (eg hyperlipidaemia, hypertriglyceridaemia)MedDRA version: 18.0Level: LLTClassification code 10020667Term: HyperlipidemiaSystem Organ Class: 100000004861EUCTR2013-001517-32-SEKowa Research Europe350
进行中（未招募）
不适用
To find a safe and effective dose of K-877 for targeted patientsdyslipidemia (eg hyperlipidaemia, hypertriglyceridaemia)MedDRA version: 18.0Level: LLTClassification code 10020667Term: HyperlipidemiaSystem Organ Class: 100000004861EUCTR2013-001517-32-DEKowa Research Europe350